Medical & ProductDisclaimer
Please read this disclaimer carefully before exploring our therapeutic formulations, dermatological solutions, or scientific literature.
Not a Substitute for Professional Medical Advice
The information provided across Phasecor Healthcare digital platforms (including phasecor.com, phasecorhealthcare.com, packaging brochures, and digital literature) is intended strictly for general informational, educational, and scientific reference purposes. It should not be considered, relied upon, or used as a substitute for professional clinical advice, medical diagnosis, or personalized treatment plans.
1Product Information & Scientific Specifications
All product descriptions, key active compositions, molecular targets, packaging images, and specifications on this website are provided for reference purposes. While we maintain rigorous quality assurance to ensure product specifications reflect our cGMP manufacturing standards:
- Visual packaging representations may undergo minor packaging redesigns or regulatory labeling modifications over time.
- Batch numbers, expiration dates, and manufacturing licensing details are printed directly on the primary and secondary packaging containers.
- Always inspect the physical product seal, label, and packaging inserts prior to initial administration.
2Individual Cutaneous & Physiological Variations
Individual clinical outcomes, cutaneous absorption rates, and therapeutic responses vary significantly based on unique factors, including:
Phasecor Healthcare does not guarantee identical results across all users. Statements regarding restorative or protective efficacy reflect active ingredient research and clinical formulation models.
Recommended Dermatological Patch Test Protocol
Prior to full application of any new topical skincare formulation (including UVoThera Sunscreen or concentrated active serums), Phasecor strongly recommends conducting an initial patch test:
- Apply a small dime-sized amount of formulation to a discreet area (such as the inner forearm or behind the ear).
- Leave the product undisturbed for 24 to 48 hours.
- If redness, itching, burning, inflammation, or irritation develops, discontinue use immediately and cleanse the area.
- If irritation persists, consult a dermatologist or healthcare professional.
4Prescription Formulations & Medical Consultations
Therapeutic formulations (such as UTIcor™, Chronicor™, OvaPhase™, and Primathion™) are formulated for specialized clinical pathways.
- Nothing on this website constitutes a prescription, medical advice, or physician-patient relationship.
- Never discontinue, alter, or delay seeking professional medical treatment because of information read on our website.
- Always seek the advice of your physician, dermatologist, or licensed healthcare provider with any questions regarding a medical condition.
5Limitation of Liability for Misuse
Phasecor Healthcare, its officers, medical advisors, and partners shall not be held liable for any adverse reactions, allergic episodes, direct, indirect, or consequential damages resulting from:
- Improper application, off-label administration, or failure to follow labeled instructions.
- Concurrent use of incompatible active chemical compounds or dermatological treatments.
- Reliance on informational summaries as clinical diagnostics.
6External Links & Modifications
This website may link to external scientific journals, regulatory repositories, or clinical trials. Phasecor does not endorse and is not responsible for the accuracy or findings of third-party external literature.
Phasecor reserves the right to modify, amend, or update this Disclaimer at any time without prior individual notice. Continued interaction with our website after modifications indicates your acceptance.
Clinical & Regulatory Inquiries
For medical dialogue, formulation inquiries, or regulatory queries, please reach out to our team: